Although proton pump inhibitors (PPIs) are effective in treating gastric acid-related disorders, their usage is linked with various side effects. 1 Evidence suggests that pantoprazole, a PPI, is associated with lower incidences of drug interaction, and is comparatively effective and safe in patients with gastric diseases. 1, 2 To know your opinion on the same, please help us by taking this 2 minutes survey! References: Wedemeyer RS and Blume H. Drug safety. 2014 Apr;37(4):201-11. Rongcheng XU, et al., Chinese Journal of Primary Medicine and Pharmacy.
2017 Jan 1;24(9):1373-7. Ren F, et al., Chinese Journal of Primary Medicine and Pharmacy. 2017 Jan 1;24(21):3299-302. Moayyedi P, et al., Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2019 Aug ;157(2):403-12. Turedi…
